Clinical Trials on Castrate Sensitive Prostate Cancer in Germany
Total 255 results
-
Janssen Research & Development, LLCRecruitingMetastatic Castrate-sensitive Prostate CancerUnited States, France, Mexico, Germany, Australia, Brazil, Canada, China, Poland
-
IpsenTerminatedMetastatic Castrate Resistant Prostate CancerFrance, Spain, Poland, Belgium, Germany, Italy, Denmark, Lithuania, United Kingdom, Czechia, Hungary
-
Jena University HospitalBayerRecruitingMetastatic Hormone-Sensitive Prostate Cancer (mHSPC)Germany
-
Janssen-Cilag Ltd.RecruitingMetastatic Hormone-sensitive Prostate CancerFrance, Germany, Spain, Greece, United Kingdom, Austria
-
AstraZenecaActive, not recruitingHormone-Sensitive Prostate CancerUnited States, Belgium, Spain, Canada, Poland, Argentina, India, Taiwan, Thailand, Vietnam, Turkey, Russian Federation, France, Germany, Korea, Republic of, Brazil, Mexico, Peru, Philippines, China, United Kingdom, Hong Kong, Israel, ... and more
-
AstraZenecaRecruitingMetastatic Castration-Sensitive Prostate CancerUnited States, Canada, Spain, United Kingdom, Italy, Australia, Korea, Republic of, Belgium, Germany, Japan, Peru, France, China, India, Taiwan, Thailand, Austria, Brazil, Turkey, Malaysia, Finland, Netherlands, Chile, Hungary, Poland, Sw...
-
Astellas Pharma Global Development, Inc.Medivation LLC, a wholly owned subsidiary of Pfizer Inc.Active, not recruitingMetastatic Hormone Sensitive Prostate CancerKorea, Republic of, Japan, United States, Argentina, Australia, Belgium, Canada, Chile, Denmark, Finland, France, Germany, Israel, Italy, Netherlands, New Zealand, Poland, Romania, Russian Federation, Slovakia, Spain, Sweden, Taiwan, United...
-
Janssen Research & Development, LLCActive, not recruitingMetastatic Castration-sensitive Prostate CancerUnited States, Italy, China, Korea, Republic of, Canada, Australia, United Kingdom, Hungary, France, Taiwan, Thailand, Germany, Malaysia, Denmark, Russian Federation, New Zealand, Ukraine, Bulgaria, Israel, Spain, Turkey, Sweden, Cz... and more
-
BayerOrion Corporation, Orion PharmaCompletedMetastatic Hormone-sensitive Prostate CancerBelgium, France, Sweden, China, Canada, United States, Spain, Taiwan, Japan, Finland, Korea, Republic of, Australia, Brazil, Czechia, Israel, Italy, Netherlands, Russian Federation, Bulgaria, United Kingdom, Germany, Poland, Mexico
-
Merck Sharp & Dohme LLCActive, not recruitingMetastatic Hormone-Sensitive Prostate CancerTaiwan, Poland, United States, Australia, Austria, Brazil, Canada, Chile, China, Colombia, Denmark, Finland, France, Germany, Ireland, Israel, Italy, Japan, Korea, Republic of, Mexico, Netherlands, New Zealand, Peru, Russian Federation, Spai... and more
-
AstraZenecaParexelCompletedHealthy Volunteers (Intended Indication: Metastatic Patients With Triple Negative or HR+ Breast Cancer, or Hormone Sensitive Prostate Cancer)Germany
-
BayerActive, not recruitingMetastatic Castrate Resistant Prostate Cancer (mCRPC)Spain, Korea, Republic of, United Kingdom, Australia, Hong Kong, Singapore, Taiwan, Lithuania, Russian Federation, Turkey, France, Israel, Czechia, Italy, Germany, Finland, Austria, Poland, Hungary
-
Universität des SaarlandesRecruitingProstate Cancer Metastatic | Advanced Prostate Carcinoma | Castration Resistant Prostatic CancerGermany
-
Ferring PharmaceuticalsCompleted
-
Technical University of MunichRecruitingCastration-resistant Prostate CancerGermany
-
University of HohenheimUniversity Hospital Tuebingen; Quercegen PharmaceuticalsUnknownPrimary Prevention of Prostate CancerGermany
-
Martini-Klinik am UKE GmbHErich und Gertrud Roggenbuck-Stiftung zur Förderung der KrebsforschungCompleted
-
CS Diagnostics GmbHAix ScientificsTerminatedProstate Cancer Patients Treated by RadiotherapyGermany
-
Novartis PharmaceuticalsCompletedCastration Resistant Prostate CancerGermany
-
Zealand University HospitalUniversity Hospital Schleswig-HolsteinUnknownHormone-refractory Prostate CancerDenmark, Germany
-
Astellas Pharma Europe B.V.Medivation, Inc.CompletedHealthy Subjects | Relative Bioavailability | Castration Resistant Prostate Cancer (CRPC) | MDV3100Germany
-
Technische Universität DresdenCompletedProstate Cancer | Oligometastatic DiseaseGermany
-
Universitätsklinikum Hamburg-EppendorfBoehringer IngelheimTerminated
-
ProteoMediX AGCompletedIndication for Prostate Biopsy Due to Suspected Prostate CancerAustria, Germany, Denmark
-
CureVacCompletedHormonal Refractory Prostate CancerGermany, Italy
-
German Cancer Research CenterUniversity Hospital Freiburg; ABX CRO; Friedrich-Alexander-Universität Erlangen-NürnbergCompletedProstate Cancer | Prostate Cancer Metastatic | High-risk Prostate Cancer | Lymphnode MetastasisAustria, Germany
-
University Hospital TuebingenRecruiting
-
Heidelberg UniversityCompleted
-
University Hospital TuebingenCompleted
-
Martini-Klinik am UKE GmbHRecruiting
-
University Hospital TuebingenRecruitingProstate CancerGermany
-
Martini-Klinik am UKE GmbHEindhoven University of TechnologyCompleted
-
Heidelberg UniversityKlaus Tschira Stiftung gGmbHCompleted
-
Heinrich-Heine University, DuesseldorfCompletedProstate CancerGermany
-
Heinrich-Heine University, DuesseldorfCompleted
-
European Organisation for Research and Treatment...Terminated
-
University Hospital ErlangenUnknown
-
University of Erlangen-Nürnberg Medical SchoolRecruiting
-
University of Erlangen-Nürnberg Medical SchoolUnknown
-
University Hospital TuebingenRecruitingProstate Cancer RecurrentGermany
-
Heinrich-Heine University, DuesseldorfUnknown
-
BayerCompletedBone Metastatic Castration-resistant Prostate CancerGermany, Netherlands, Denmark
-
Wuerzburg University HospitalUniversitaire Ziekenhuizen KU LeuvenTerminatedProstate Cancer | Radical ProstatectomyGermany
-
Dr. Markus HartenbachCompleted
-
St. Antonius Hospital GronauCompleted
-
University of MagdeburgCompleted
-
Technische Universität DresdenRadiation Oncology Working Group of the German Cancer Society; German Consortium... and other collaboratorsRecruiting
-
Heinrich-Heine University, DuesseldorfGerman Cancer Research CenterUnknown
-
Association Pour La Recherche des Thérapeutiques...CompletedProstate Cancer MetastaticFrance, Germany